What is the treatment for viral gastritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Viral Gastroenteritis

Viral gastroenteritis is primarily treated with oral rehydration therapy (ORT), as it is a self-limited illness where the main risk is dehydration and electrolyte imbalance. 1, 2

First-Line Management

Rehydration

  • Oral rehydration therapy (ORT) using oral rehydration solution (ORS) is the first-line treatment 2
    • As effective as intravenous therapy for mild to moderate dehydration 3
    • Should be attempted before considering IV fluids
  • Reserve intravenous (IV) fluid therapy for patients with:
    • Severe dehydration
    • Inability to tolerate oral fluids
    • Altered mental status
    • Shock 2

Antiemetics

  • Ondansetron may be given to facilitate oral rehydration in children >4 years and adolescents with vomiting 2
    • Improves tolerance of oral fluids and reduces hospitalization rates 4
    • Dosage: 0.15 mg/kg IV 4

Nutrition

  • Continue normal feeding during illness
  • Resume age-appropriate diet during or immediately after rehydration 2
  • Breast milk has protective effects against viral enteric infections; infants can usually be "fed through" an episode 1, 2
  • Avoid foods high in simple sugars as they can worsen diarrhea through osmotic effects 2

Special Considerations

Antimotility Agents

  • Should NOT be given to children <18 years with acute diarrhea 2
  • Loperamide may be given to immunocompetent adults with acute watery diarrhea 2
  • Avoid antimotility agents in cases of inflammatory diarrhea or diarrhea with fever 2

High-Risk Populations

  • Children: Higher risk of dehydration; respond well to ORT 1
  • Elderly: At increased risk for severe dehydration and electrolyte imbalances 2
  • Immunocompromised: May experience prolonged viral shedding and more severe disease 2
    • In severe cases of adenovirus-associated diarrhea in immunocompromised patients, cidofovir may be considered (5 mg/kg IV weekly) despite its nephrotoxicity 1
    • For CMV enteritis in immunocompromised patients, ganciclovir (5 mg/kg bid IV for 2-3 weeks) followed by maintenance therapy is recommended 1

Duration of Symptoms

  • Most viral gastroenteritis is self-limited:
    • Norovirus: 24-72 hours
    • Rotavirus: 4-7 days
    • Adenovirus: ≥1 week 2

Monitoring and Follow-up

  • Monitor for signs of dehydration: decreased urine output, dry mucous membranes, decreased skin turgor
  • Electrolyte measurements generally not necessary except in severe dehydration requiring hospitalization 5
  • Approximately 9% of patients may develop post-infectious irritable bowel syndrome 2

Prevention

  • Rigorous handwashing with soap and water for at least 20 seconds
  • Rotavirus vaccination for children
  • Food handlers should not prepare food for at least 2 days after resolution of illness
  • Clean and disinfect contaminated surfaces with chlorine bleach solution 2

Common Pitfalls to Avoid

  1. Overreliance on IV fluids when ORT would be sufficient
  2. Unnecessary use of antimotility agents in children or with inflammatory diarrhea
  3. Premature discontinuation of feeding during illness
  4. Failure to recognize dehydration in high-risk populations (young children, elderly)
  5. Unnecessary laboratory testing in mild cases

The key to successful management is early recognition and prompt initiation of appropriate rehydration therapy, with special attention to vulnerable populations who may require more aggressive intervention.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Gastroenteritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acute gastroenteritis: from guidelines to real life.

Clinical and experimental gastroenterology, 2010

Research

Emergency department treatment of viral gastritis using intravenous ondansetron or dexamethasone in children.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.